BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38479120)

  • 1. How to develop new systemic treatments in ultra-rare cancers with high unmet needs? The case of alveolar soft-part sarcoma.
    Stacchiotti S; Bouche G; Herold R; Pantziarka P; Schuster K; Wilson R; Pignatti F; Kasper B
    Eur J Cancer; 2024 May; 202():114003. PubMed ID: 38479120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial.
    Blay JY; Chevret S; Le Cesne A; Brahmi M; Penel N; Cousin S; Bertucci F; Bompas E; Ryckewaert T; Soibinet P; Boudou-Rouquette P; Saada Bouzid E; Soulie P; Valentin T; Lotz JP; Tosi D; Neviere Z; Cancel M; Ray-Coquard I; Gambotti L; Legrand F; Lamrani-Ghaouti A; Simon C; Even C; Massard C
    Lancet Oncol; 2023 Aug; 24(8):892-902. PubMed ID: 37429302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alveolar soft part sarcoma metastatic to the mandible: A report and review of literature.
    Peters SM; Perrino MA; Yoon AJ; Philipone EM
    J Stomatol Oral Maxillofac Surg; 2017 Dec; 118(6):379-382. PubMed ID: 28774857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis, Prognosis, and Treatment of Alveolar Soft-Part Sarcoma: A Review.
    Paoluzzi L; Maki RG
    JAMA Oncol; 2019 Feb; 5(2):254-260. PubMed ID: 30347044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alveolar Soft-Part Sarcoma in Olfactory Cleft: A Case Report and Clinicopathological Review.
    Alromaih S; Alqaryan S; Alabood S; Alabaishi S; Ajlan A; Alsuhaibani A; Sumaily I; Alsolami A
    Ear Nose Throat J; 2022 Jun; 101(5):336-341. PubMed ID: 32931333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary intraosseous alveolar soft part sarcoma: Report of two cases with radiologic-pathologic correlation.
    Pena-Burgos EM; Pozo-Kreilinger JJ; Tapia-Viñe M; Redondo A; Mendiola-Sabio M; Ortiz-Cruz EJ
    Ann Diagn Pathol; 2023 Feb; 62():152078. PubMed ID: 36543620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. iCREATE: imaging features of primary and metastatic alveolar soft part sarcoma from the EORTC CREATE study.
    Mcaddy NC; Saffar H; Litière S; Jespers P; Schöffski P; Messiou C
    Cancer Imaging; 2020 Oct; 20(1):79. PubMed ID: 33121537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities.
    Stacchiotti S; Frezza AM; Blay JY; Baldini EH; Bonvalot S; Bovée JVMG; Callegaro D; Casali PG; Chiang RC; Demetri GD; Demicco EG; Desai J; Eriksson M; Gelderblom H; George S; Gounder MM; Gronchi A; Gupta A; Haas RL; Hayes-Jardon A; Hohenberger P; Jones KB; Jones RL; Kasper B; Kawai A; Kirsch DG; Kleinerman ES; Le Cesne A; Lim J; Chirlaque López MD; Maestro R; Marcos-Gragera R; Martin Broto J; Matsuda T; Mir O; Patel SR; Raut CP; Razak ARA; Reed DR; Rutkowski P; Sanfilippo RG; Sbaraglia M; Schaefer IM; Strauss DC; Sundby Hall K; Tap WD; Thomas DM; van der Graaf WTA; van Houdt WJ; Visser O; von Mehren M; Wagner AJ; Wilky BA; Won YJ; Fletcher CDM; Dei Tos AP; Trama A
    Cancer; 2021 Aug; 127(16):2934-2942. PubMed ID: 33910263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Intracerebral Alveolar Soft Part Sarcoma: Report of a Case and Review of the Literature.
    Caporalini C; Giordano F; Moscardi S; Di Stefano G; Lenge M; Di Giacomo G; Basile M; Zin A; Mura R; Scagnet M; Alaggio R; Sardi I; Genitori L; Buccoliero AM
    Int J Surg Pathol; 2022 Apr; 30(2):195-199. PubMed ID: 34142883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case report and literature review on nephrogenic alveolar soft part sarcoma: clinicopathological manifestations and genetic features.
    Wang X; Yu J; Fan X; Ma S; Xie X; Gao N; Huang S; Lu A
    BMC Urol; 2023 Feb; 23(1):17. PubMed ID: 36782230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
    Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
    Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duodenal metastasis of alveolar soft part sarcoma.
    Willekens I; Paradisi C; Sarria L; Puertas A; Pac J; Mayayo E
    JBR-BTR; 2011; 94(5):287-9. PubMed ID: 22191294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paediatric and adolescent alveolar soft part sarcoma: A joint series from European cooperative groups.
    Orbach D; Brennan B; Casanova M; Bergeron C; Mosseri V; Francotte N; Van Noesel M; Rey A; Bisogno G; Pierron G; Ferrari A
    Pediatr Blood Cancer; 2013 Nov; 60(11):1826-32. PubMed ID: 23857870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alveolar soft part sarcoma of the retro peritoneum.
    Xin FY; Rana N; Ming Z; Lang YB
    J Cancer Res Ther; 2010; 6(1):117-9. PubMed ID: 20479565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alveolar soft part sarcoma occurring on the abdominal wall of a 2-year-old child.
    Jia Y; Wu D; Shang C; Yu J; Zhang KR
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):e80-2. PubMed ID: 21317811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial.
    Wilky BA; Trucco MM; Subhawong TK; Florou V; Park W; Kwon D; Wieder ED; Kolonias D; Rosenberg AE; Kerr DA; Sfakianaki E; Foley M; Merchan JR; Komanduri KV; Trent JC
    Lancet Oncol; 2019 Jun; 20(6):837-848. PubMed ID: 31078463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced alveolar soft part sarcoma responds to apatinib.
    Zhou Y; Tang F; Wang Y; Min L; Luo Y; Zhang W; Shi R; Duan H; Tu C
    Oncotarget; 2017 Jul; 8(30):50314-50322. PubMed ID: 28679123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group.
    Malouf GG; Beinse G; Adam J; Mir O; Chamseddine AN; Terrier P; Honore C; Spano JP; Italiano A; Kurtz JE; Coindre JM; Blay JY; Le Cesne A
    Oncologist; 2019 Jul; 24(7):980-988. PubMed ID: 30626710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial.
    Judson I; Morden JP; Kilburn L; Leahy M; Benson C; Bhadri V; Campbell-Hewson Q; Cubedo R; Dangoor A; Fox L; Hennig I; Jarman K; Joubert W; Kernaghan S; López Pousa A; McNeil C; Seddon B; Snowdon C; Tattersall M; Toms C; Martinez Trufero J; Bliss JM
    Lancet Oncol; 2019 Jul; 20(7):1023-1034. PubMed ID: 31160249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alveolar soft part sarcoma: progress toward improvement in survival? A population-based study.
    Fujiwara T; Nakata E; Kunisada T; Ozaki T; Kawai A
    BMC Cancer; 2022 Aug; 22(1):891. PubMed ID: 35971085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.